Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Range Rule of Thumb to Interpret Standard Deviation01:13

Range Rule of Thumb to Interpret Standard Deviation

The range rule of thumb in statistics helps us calculate a dataset's minimum and maximum values with known standard deviation. This rule is based on the concept that 95% of all values in a dataset lie within two standard deviations from the mean.
For instance, the range rule of thumb can be used to find the tallest and the shortest student in a class, given the mean student height and standard deviation. If the mean student height is 1.6 m and the standard deviation, s is 0.05 m, the height of...
Interpretation of Confidence Intervals01:19

Interpretation of Confidence Intervals

A confidence interval is a better estimate of the population than a point estimate, as it uses a range of values from a sample instead of a single value.
Confidence intervals have confidence coefficients that are crucial for their interpretation. The most common confidence coefficients are 0.90, 0.95, and 0.99, which can be written as percentages–90%, 95%, and 99%, respectively.
Suppose a person calculates a confidence interval with a confidence coefficient of 0.95. In that case, they can...
Uncertainty: Confidence Intervals00:54

Uncertainty: Confidence Intervals

The confidence interval is the range of values around the mean that contains the true mean. It is expressed as a probability percentage. The interpretation of a 95% confidence interval, for instance, is that the statistician is 95% confident that the true mean falls within the interval. The upper and lower limits of this range are known as confidence limits. The confidence limits for the true mean are estimated from the sample's mean, the standard deviation, and the statistical factor 't,' or...
Variability: Analysis01:11

Variability: Analysis

Measures of variability are statistical metrics that reveal the dispersion pattern within a dataset. They are pivotal in biostatistics, providing insights into the heterogeneity within health and biological data. Variability signifies the degree to which data points diverge from one another, helping researchers understand the potential range of values and associated uncertainty within the data.
The range is a simple measure of variability, indicating the difference between the highest and...
Bioequivalence Data: Statistical Interpretation01:16

Bioequivalence Data: Statistical Interpretation

The statistical interpretation of bioequivalence data is a significant aspect of pharmaceutical research. Bioequivalence refers to the absence of any significant difference in the rate and extent to which the active ingredient in pharmaceutical products becomes available at the site of drug action when administered at the same molar dose under similar conditions. This helps determine if different drug products have similar absorption rates, ensuring their interchangeability.Statistical...
Dosage Regimen: Individualization01:24

Dosage Regimen: Individualization

Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Voriconazole therapy and CYP2C19 phenotype: identifying patients who may need alternative antifungal therapy.

The Journal of antimicrobial chemotherapy·2026
Same author

Embedding Passive Monitoring Into Global Health and Longitudinal Patient Care.

JMIR formative research·2025
Same author

Capitalizing on the GLP-1 RA revolution for behavioral health through digital companions.

Digital health·2025
Same author

Substances and substance combinations among accidental substance-related acute toxicity deaths (AATDs) in Canada from 2016 to 2017.

BMC public health·2025
Same author

Editorial: Digital remote patient monitoring in neurodegenerative diseases.

Frontiers in digital health·2025
Same author

Teledermatology to Support Self-Care in Chronic Spontaneous Urticaria.

JMIR dermatology·2025

Related Experiment Video

Updated: Jun 25, 2026

Absolute Quantification of Aβ1-42 in CSF Using a Mass Spectrometric Reference Measurement Procedure
08:40

Absolute Quantification of Aβ1-42 in CSF Using a Mass Spectrometric Reference Measurement Procedure

Published on: March 21, 2017

Standardisation of reference intervals: an Australasian view.

Graham Jones1, Antony Barker

  • 1Department of Chemical Pathology, St Vincent's Hospital, NSW 2010, Australia. Gjones@stvincents.com.au

The Clinical Biochemist. Reviews
|April 9, 2008
PubMed
Summary

This article discusses the need for consistent laboratory testing standards across Australasia. By aligning reference ranges and reporting methods, medical professionals can better track patient health data over time, reducing the risk of misinterpretation when results come from different facilities.

Keywords:
laboratory standardizationclinical diagnosticsquality assurancehealth informatics

Frequently Asked Questions

More Related Videos

Evaluation of a Point-of-Care Testing Analyzer for Measuring Peripheral Blood Leukocytes
05:58

Evaluation of a Point-of-Care Testing Analyzer for Measuring Peripheral Blood Leukocytes

Published on: March 22, 2022

Reproducibility and Harmonization in Research Using Biological Standards: The Example of Platelet Agonist Collagen-Related Peptide
04:50

Reproducibility and Harmonization in Research Using Biological Standards: The Example of Platelet Agonist Collagen-Related Peptide

Published on: August 4, 2023

Related Experiment Videos

Last Updated: Jun 25, 2026

Absolute Quantification of Aβ1-42 in CSF Using a Mass Spectrometric Reference Measurement Procedure
08:40

Absolute Quantification of Aβ1-42 in CSF Using a Mass Spectrometric Reference Measurement Procedure

Published on: March 21, 2017

Evaluation of a Point-of-Care Testing Analyzer for Measuring Peripheral Blood Leukocytes
05:58

Evaluation of a Point-of-Care Testing Analyzer for Measuring Peripheral Blood Leukocytes

Published on: March 22, 2022

Reproducibility and Harmonization in Research Using Biological Standards: The Example of Platelet Agonist Collagen-Related Peptide
04:50

Reproducibility and Harmonization in Research Using Biological Standards: The Example of Platelet Agonist Collagen-Related Peptide

Published on: August 4, 2023

Area of Science:

  • Clinical pathology standardization within laboratory medicine
  • Health informatics and reference intervals management

Background:

No prior work had resolved the challenges of interpreting cumulative pathology data across diverse regional laboratories. It was already known that desktop software programs allow physicians to aggregate test results from multiple sources. This capability creates a risk of confusion if laboratories report findings using inconsistent metrics. Prior research has shown that disparate analytical techniques often yield varying values for identical patient samples. That uncertainty drove the need for a unified approach to reporting. Standardizing these metrics remains a significant hurdle for modern healthcare systems. This gap motivated a closer look at how regional databases function in practice. Experts recognize that without common benchmarks, clinical decision-making may suffer from avoidable errors.

Purpose Of The Study:

The aim of this study is to propose a framework for the standardization of reference intervals across Australasian laboratories. This initiative seeks to address the confusion caused by inconsistent reporting in regional databases. The authors identify a need for common benchmarks to facilitate the accurate assessment of cumulative patient data. This work addresses the challenge of integrating results from different laboratories into doctors' desktop programs. The research explores how to manage analytical methods that yield significantly different values. The study motivates the formation of a collaborative network to oversee these reporting standards. The authors seek to define how professional bodies can lead the ongoing review of these metrics. This effort intends to ensure that diagnostic data remains reliable as testing technologies evolve.

Main Methods:

The review approach evaluates the organizational requirements for achieving consistency in laboratory reporting. Investigators examine the necessity of structured collaboration between regional quality assurance entities. This study assesses how professional leadership facilitates the ongoing definition of common benchmarks. The analysis considers the integration of expert clinical perspectives into the decision-making process. Researchers investigate the criteria for analytical agreement based on comparative testing of patient specimens. The review approach emphasizes the importance of adapting to new diagnostic instruments. This evaluation focuses on the logistical challenges of managing data across diverse laboratory settings. The methodology centers on synthesizing best practices for regional standardization efforts.

Main Results:

Key findings from the literature indicate that regional databases improve patient care by enabling the assessment of cumulative data. The authors report that inconsistent metrics across laboratories create a significant risk of clinical confusion. Findings suggest that analytical methods producing divergent results must be clearly communicated to avoid misinterpretation. The literature highlights that setting valid benchmarks requires a formal organizational structure. Evidence shows that expert clinician input is vital for determining appropriate ranges. The review indicates that analytical agreement between facilities depends on comparison studies using patient samples. The authors find that a network of quality assurance groups is needed to share the workload. Results demonstrate that these intervals must be reviewed whenever new diagnostic techniques are introduced.

Conclusions:

The authors propose establishing a network of quality assurance groups to oversee these tasks. Leadership from professional bodies will guide the ongoing definition of standard ranges. These groups must adapt to the evolving landscape of diagnostic instrumentation and techniques. Regular reviews ensure that benchmarks remain relevant as testing environments change over time. The organizational structure will incorporate expert clinical feedback to refine these values. This synthesis highlights the necessity of collaborative efforts across the Australasian region. Standardized reporting practices will ultimately support more reliable assessment of patient health trends. Future efforts should focus on maintaining these shared agreements to ensure long-term consistency in laboratory outputs.

The researchers propose that a network of quality assurance groups, led by the Australasian Association of Clinical Biochemists (AACB) and the Royal College of Pathologists of Australasia (RCPA), should define and maintain these benchmarks to ensure consistency across different testing facilities.

The authors suggest that laboratories must perform comparison studies using actual patient samples to verify that their analytical methods produce results that are in agreement with one another.

The authors argue that when analytical methods yield significantly different results, laboratories must report these findings in a specific manner to prevent clinicians from making inappropriate interpretations of the data.

These databases allow doctors to easily assess cumulative patient data, but they risk causing confusion if the contributing laboratories do not provide standardized results and common reference ranges.

The authors identify that the process requires an organizational framework that accounts for all relevant factors, including the professional opinions of expert clinicians, to set valid and appropriate ranges.

The researchers propose that these intervals require periodic review as the testing environment shifts due to the introduction of novel instruments and advanced diagnostic techniques.